These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16398690)

  • 1. Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease.
    Southerland JH; Taylor GW; Moss K; Beck JD; Offenbacher S
    Periodontol 2000; 2006; 40():130-43. PubMed ID: 16398690
    [No Abstract]   [Full Text] [Related]  

  • 2. Periodontal disease and diabetes mellitus: discussion, conclusions, and recommendations.
    Lamster IB; Lalla E
    Ann Periodontol; 2001 Dec; 6(1):146-9. PubMed ID: 11887457
    [No Abstract]   [Full Text] [Related]  

  • 3. The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT).
    Haslbeck KM; Schleicher E; Bierhaus A; Nawroth P; Haslbeck M; Neundörfer B; Heuss D
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):288-91. PubMed ID: 15926115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Accumulation of AGE (advanced glycosylation end-products) in the aging process, in diabetes mellitus and in chronic renal failure].
    Wisotzky J; Sommer M; Schubert K; Stein G
    Med Klin (Munich); 1996 Jul; 91(7):454-7. PubMed ID: 8756114
    [No Abstract]   [Full Text] [Related]  

  • 5. The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy.
    Lukic IK; Humpert PM; Nawroth PP; Bierhaus A
    Ann N Y Acad Sci; 2008 Apr; 1126():76-80. PubMed ID: 18448798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products: sparking the development of diabetic vascular injury.
    Goldin A; Beckman JA; Schmidt AM; Creager MA
    Circulation; 2006 Aug; 114(6):597-605. PubMed ID: 16894049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease.
    Maczurek A; Shanmugam K; Münch G
    Ann N Y Acad Sci; 2008 Apr; 1126():147-51. PubMed ID: 18448809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship of periodontitis and diabetes mellitus].
    Kasaj A; Gortan-Kasaj A; Willerhausen B; Hoffmann O; Angelov N; Zafiropoulos GG
    Acta Med Croatica; 2007 Sep; 61(4):369-74. PubMed ID: 18044471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nuclear factor-kappa B (NF-kappa B) in inflammation, periodontitis, and atherogenesis.
    Nichols TC; Fischer TH; Deliargyris EN; Baldwin AS
    Ann Periodontol; 2001 Dec; 6(1):20-9. PubMed ID: 11887466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing.
    Yan SF; Yan SD; Herold K; Ramsamy R; Schmidt AM
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):511-24, viii. PubMed ID: 16959583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycosylation end products and nutrition--a possible relation with diabetic atherosclerosis and how to prevent it.
    Xanthis A; Hatzitolios A; Koliakos G; Tatola V
    J Food Sci; 2007 Oct; 72(8):R125-9. PubMed ID: 17995617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycoxidation products and impaired diabetic wound healing.
    Peppa M; Stavroulakis P; Raptis SA
    Wound Repair Regen; 2009; 17(4):461-72. PubMed ID: 19614910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyphenols and inflammation: basic interactions.
    Biesalski HK
    Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):724-8. PubMed ID: 18089954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of height with inflammation and periodontitis: the Study of Health in Pomerania.
    Meisel P; Kohlmann T; Kocher T
    J Clin Periodontol; 2007 May; 34(5):390-6. PubMed ID: 17355364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
    Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
    Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes.
    Tchaikovski V; Olieslagers S; Böhmer FD; Waltenberger J
    Circulation; 2009 Jul; 120(2):150-9. PubMed ID: 19564559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylglyoxal: possible link between hyperglycaemia and immune suppression?
    Price CL; Knight SC
    Trends Endocrinol Metab; 2009 Sep; 20(7):312-7. PubMed ID: 19709901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
    Stirban A; Negrean M; Stratmann B; Gawlowski T; Horstmann T; Götting C; Kleesiek K; Mueller-Roesel M; Koschinsky T; Uribarri J; Vlassara H; Tschoepe D
    Diabetes Care; 2006 Sep; 29(9):2064-71. PubMed ID: 16936154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
    Kanková K
    Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.